The probability of cost-effectiveness.
The probability of cost-effectiveness.
复制标题
DOI：
10.1186/1471-2288-2-5
复制
发表时间：
2002-01-01
影响因子：
4
通讯作者：
Stevens, John W
中科院分区：
文献类型：
--
作者：
O'Hagan, Anthony;Stevens, John W
背景：竞争性医疗干预之间成本效益比较的研究导致了量化成本效益的各种建议。各种方法之间的区别可能很微妙，本文的目的之一就是澄清一些重要的区别。讨论：我们在个人、患者水平、增量净收益的框架下讨论替代措施。我们特别研究了Willan提出的个人成本效益的概率。摘要：我们认为这是对成本效益措施范围的一个有用的补充，但对于大多数决策者来说，这将是次要的。我们还证明Willan提出的概率估计在逻辑上是有缺陷的。
BACKGROUND: The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose of this article is to clarify some important distinctions.DISCUSSION: We discuss alternative measures in the framework of individual, patient-level, incremental net benefits. In particular we examine the probability of cost-effectiveness for an individual, proposed by Willan.SUMMARY: We argue that this is a useful addition to the range of cost-effectiveness measures, but will be of secondary interest to most decision makers. We also demonstrate that Willan's proposed estimate of this probability is logically flawed.